Evidence map›Paper›PMID 41020579›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

Hsa_circRNA_0101125 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma via miR-143-3p/ZNF148 Axis.

Hao Chen, Songtao Xue, Shiqiang Cao, Jiarong Zhang, Yuanpu Wei, Chun Chen, Guobing Xu

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hsa_circRNA_0101125 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma via miR-143-3p/ZNF148 Axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hao ChenDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou city, Fujian province, China.
Songtao XueDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou city, Fujian province, China.
Shiqiang CaoDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou city, Fujian province, China.
Jiarong ZhangDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou city, Fujian province, China.
Yuanpu WeiDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou city, Fujian province, China.
Chun ChenDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou city, Fujian province, China.ORCID https://orcid.org/0000-0001-9264-8020
Guobing XuDepartment of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou city, Fujian province, China.

Funding

Fujian Medical UniversityFujian Provincial Natural Science Foudation of China 2019J05085Joint Funds for innovation of Science and Technology, Fujian Provionce 2020Y9100Startup Fund for Scientific research, Fujian Mecial University 2020QH1067
6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) is a highly invasive and metastatic malignancy. Circular RNAs (circRNAs), including hsa_circRNA_0101125, have been implicated in regulating cancer metastasis. But its potential roles in ESCC remain underexplored, particularly in relation to miR-143-3p. This study aimed to investigate the role of hsa_circRNA_0101125/miR-143-3p in the occurrence and development of ESCC. KYSE150 and ECA109 cells were used as in vitro models to evaluate the biological effects of hsa_circRNA_0101125. The interaction between ZNF148 and miR-143-3p was confirmed by dual-luciferase assay. To assess the functional role of this pathway, cells were transfected with sh-hsa_circRNA_0101125 vectors and/or miR-143-3p inhibitors, followed by assays for cell viability (CCK-8), migration (wound healing assay), and invasion (Transwell assay). Transcriptions and expressions of hsa_circRNA_0101125, miR-143-3p, and ZNF148 were measured by RT-qPCR and western blot. Results showed that hsa_circRNA_0101125 was localized in the cytoplasm and negatively regulated miR-143-3p, which targeted ZNF148. Inhibition of hsa_circRNA_0101125 significantly reduced cell viability, migration, and invasion, downregulated ZNF148 and Vimentin, and upregulated miR-143-3p and E-cadherin expressions. In contrast, downregulating miR-143-3p abolished these effects. Therefore, hsa_circRNA_0101125 promotes the proliferation, migration, and invasion of ESCC cells by inhibiting the expression of miR-143-3p.

Indexed as

Cell MovementCell ProliferationDNA-Binding ProteinsEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaMicroRNAsRNA, CircularTranscription FactorsCell Line, TumorGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessDNA-Binding ProteinsMicroRNAsMIRN143 microRNA, humanRNA, CircularTranscription Factorsepithelial‐mesenchymal transitionesophageal cancerhsa_circRNA_0101125miR‐143‐3pZNF148

Identifiers

PMID41020579
PMCPMC12477985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.